Skip to main navigation Skip to search Skip to main content

Prognostic role of proton magnetic resonance spectroscopy in acute traumatic brain injury

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Proton magnetic resonance spectroscopy (MRS) is being used to evaluate individuals after acute traumatic brain injury. These studies have shown that changes in certain brain metabolites are associated with poor neurologic outcomes. The majority of MRS studies have been obtained relatively late after injury, but there have been a few reports of use early after injury to assist with outcome prediction. Altered brain metabolites may be sensitive indicators of injury and thus provide additional prognostic information when spectroscopy is done early after injury. This technology may provide a noninvasive means to evaluate early excitotoxic injury, and show changes associated with both neuronal injury and membrane disruption secondary to diffuse axonal injury. This article will review the technology of MRS, discuss its role in patient assessment after traumatic brain injury, and present a summary of our published and ongoing research. © 2006 Lippincott Williams & Wilkins, Inc.
    Original languageEnglish
    Pages (from-to)334-349
    Number of pages16
    JournalJournal of Head Trauma Rehabilitation
    Volume21
    Issue number4
    DOIs
    StatePublished - Jul 2006

    ASJC Scopus Subject Areas

    • Physical Therapy, Sports Therapy and Rehabilitation
    • Rehabilitation
    • Clinical Neurology

    Keywords

    • Diffuse axonal injury
    • Proton magnetic resonance spectroscopy
    • Traumatic brain injury
    • Predictive Value of Tests
    • Prognosis
    • Follow-Up Studies
    • Inositol/metabolism
    • Brain Injuries/metabolism
    • Humans
    • Middle Aged
    • Male
    • Glutamine/metabolism
    • Case-Control Studies
    • Creatine/metabolism
    • Glasgow Coma Scale
    • Sensitivity and Specificity
    • Nuclear Magnetic Resonance, Biomolecular
    • Adult
    • Female
    • Disability Evaluation
    • Logistic Models
    • Biomarkers/metabolism
    • Aspartic Acid/analogs & derivatives
    • Choline/metabolism
    • Adolescent
    • Aged

    Cite this